Company Filing History:
Years Active: 2012-2015
Title: Innovations of Shridhara Kanakamajalu
Introduction
Shridhara Kanakamajalu is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrug compounds. With a total of two patents to his name, his work showcases a commitment to advancing medical science.
Latest Patents
His latest patents include a compound titled "3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2-trans-[(4-chloro phenyl) cyclohexyl][1,4]naphthaquinone-atovaquone prodrug." This invention relates to an atovaquone prodrug compound, providing a process that involves the condensation of Atovaquone with 5-methyl-4-chloromethyl dioxalone in a suitable solvent system. The process is designed to yield high purity and is suitable for large-scale manufacture. Another significant patent is focused on the "Preparation of naphthoquinone compounds using 2,3-dihalonaphthoquinone." This invention utilizes 2,3-dihalonaphthoquinone compounds for making naphthoquinone compounds, showcasing versatility in chemical applications.
Career Highlights
Shridhara Kanakamajalu is currently employed at Alkem Laboratories Limited, a prominent player in the pharmaceutical industry. His role involves research and development, where he applies his expertise to create innovative solutions in drug formulation.
Collaborations
He collaborates with talented coworkers, including Shashiprabha and Kothapalli Sundarraja Rao, contributing to a dynamic research environment that fosters innovation.
Conclusion
Shridhara Kanakamajalu's contributions to pharmaceutical innovations through his patents reflect his dedication to improving healthcare solutions. His work continues to influence the field and demonstrates the importance of research in developing effective medical treatments.